Metastases of cutaneous squamous cell carcinoma in organ transplant recipients - The *SCOPE-ITSCC metastases study*

Completed

• Conditions: Skin cancer; squamous cell carcinoma; 10040900

• Registration Number: NL-OMON39568
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Organ-transplant recipients (OTR).
Histologically proven cutaneous invasive SCC at time of inclusion.

Exclusion Criteria

Lack of consent.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome of the study is the development of metastases of cutaneous<br /><br>invasive SCC within 2 years and the time period until the first metastases is<br /><br>discovered.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Assessment of risk factors for the design of future case-control studies.</p><br>